Cargando…
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947584/ https://www.ncbi.nlm.nih.gov/pubmed/35328170 http://dx.doi.org/10.3390/diagnostics12030617 |
_version_ | 1784674474815127552 |
---|---|
author | Li, Xiaoqing Sun, Lan Stucky, Andres Tu, Lingli Cai, Jin Chen, Xuelian Wu, Zhongjun Jiang, Xuhong Li, Shengwen Calvin |
author_facet | Li, Xiaoqing Sun, Lan Stucky, Andres Tu, Lingli Cai, Jin Chen, Xuelian Wu, Zhongjun Jiang, Xuhong Li, Shengwen Calvin |
author_sort | Li, Xiaoqing |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8947584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89475842022-03-25 Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” Li, Xiaoqing Sun, Lan Stucky, Andres Tu, Lingli Cai, Jin Chen, Xuelian Wu, Zhongjun Jiang, Xuhong Li, Shengwen Calvin Diagnostics (Basel) Reply MDPI 2022-03-02 /pmc/articles/PMC8947584/ /pubmed/35328170 http://dx.doi.org/10.3390/diagnostics12030617 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Reply Li, Xiaoqing Sun, Lan Stucky, Andres Tu, Lingli Cai, Jin Chen, Xuelian Wu, Zhongjun Jiang, Xuhong Li, Shengwen Calvin Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title | Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title_full | Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title_fullStr | Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title_full_unstemmed | Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title_short | Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364” |
title_sort | reply to schramm, l. comment on “li et al. bdp1 variants i1264m and v1347m significantly associated with clinical outcomes of pediatric neuroblastoma patients imply a new prognostic biomarker: a 121-patient cancer genome study. diagnostics 2021, 11, 2364” |
topic | Reply |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947584/ https://www.ncbi.nlm.nih.gov/pubmed/35328170 http://dx.doi.org/10.3390/diagnostics12030617 |
work_keys_str_mv | AT lixiaoqing replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT sunlan replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT stuckyandres replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT tulingli replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT caijin replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT chenxuelian replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT wuzhongjun replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT jiangxuhong replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 AT lishengwencalvin replytoschrammlcommentonlietalbdp1variantsi1264mandv1347msignificantlyassociatedwithclinicaloutcomesofpediatricneuroblastomapatientsimplyanewprognosticbiomarkera121patientcancergenomestudydiagnostics2021112364 |